{"id":"pf-08049820-mr2","rwe":[],"tags":[],"safety":{"drugInteractions":[{"drug":"Warfarin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Aspirin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Pentobarbital","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Phenobarbital","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Rivaroxaban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Apixaban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dabigatran","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Clopidogrel","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ticagrelor","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Prasugrel","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Cilostazol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dipyridamole","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Eptifibatide","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tirofiban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Abciximab","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Bivalirudin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Argatroban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Heparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Enoxaparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dalteparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tinzaparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Fondaparinux","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Desirudin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Bemiparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nadroparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Trometamol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Eptifibatide","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tirofiban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Abciximab","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Bivalirudin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Argatroban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Heparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Enoxaparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dalteparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tinzaparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Fondaparinux","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Desirudin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Bemiparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nadroparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Trometamol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Aspirin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Pentobarbital","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Phenobarbital","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Rivaroxaban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Apixaban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dabigatran","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Clopidogrel","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ticagrelor","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Prasugrel","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Cilostazol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dipyridamole","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Eptifibatide","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tirofiban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Abciximab","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Bivalirudin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Argatroban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Heparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Enoxaparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dalteparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tinzaparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Fondaparinux","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Desirudin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Bemiparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nadroparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Trometamol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Aspirin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Pentobarbital","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Phenobarbital","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Rivaroxaban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Apixaban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dabigatran","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Clopidogrel","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ticagrelor","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Prasugrel","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Cilostazol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dipyridamole","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Eptifibatide","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tirofiban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Abciximab","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Bivalirudin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Argatroban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Heparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Enoxaparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dalteparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tinzaparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Fondaparinux","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Desirudin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Bemiparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nadroparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Trometamol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Aspirin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Pentobarbital","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Phenobarbital","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Rivaroxaban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Apixaban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dabigatran","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Clopidogrel","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ticagrelor","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Prasugrel","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Cilostazol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dipyridamole","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Eptifibatide","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tirofiban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Abciximab","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Bivalirudin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Argatroban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Heparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Enoxaparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dalteparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tinzaparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Fondaparinux","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Desirudin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Bemiparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nadroparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Trometamol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Aspirin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Pentobarbital","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Phenobarbital","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Rivaroxaban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Apixaban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dabigatran","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Clopidogrel","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ticagrelor","action":"Monitor","effect":"Increased risk of bleeding"}],"contraindications":["HIV","Hepatitis B","Hepatitis C","Prescription drugs","Herbal supplements","History of alcohol abuse or repeated binge drinking and/or any other illicit drug use or dependence within 6 months of screening","Previous administration of an investigational product (drug or vaccine) within 30 days or 5 half-lives preceding the first dose of study intervention used in this study (whichever is longer)","I have a condition that might affect how drugs are absorbed in my body."],"specialPopulations":{"Pregnancy":"Participants who are men and women who can't have children","Geriatric use":"Not specified","Paediatric use":"Not specified","Renal impairment":"Evidence or history of clinically significant renal disease","Hepatic impairment":"Evidence or history of clinically significant hepatic disease"}},"trials":[],"aliases":[],"company":"Pfizer","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=pf-08049820-mr2","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-19T23:34:35.025613+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-19T23:34:41.291576+00:00"},"regulatory.eu":{"url":"","method":"api_direct","source":"European Medicines Agency","rawText":"","confidence":1,"sourceType":"ema_api","retrievedAt":"2026-04-19T23:34:35.093166+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=pf-08049820-mr2","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-19T23:34:41.662512+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4518706/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:34:43.082634+00:00"}},"allNames":"pf-08049820 mr2","offLabel":[],"timeline":[],"brandName":"Pf-08049820 Mr2","ecosystem":[],"isGeneric":true,"mechanism":{"target":"Unknown","novelty":"Best-in-class","modality":"Small molecule","drugClass":"Unknown","explanation":"","oneSentence":"","technicalDetail":"The mechanism of action of PF-08049820 MR2 involves targeting the molecular target, but the exact details are not available. This is a common challenge in understanding the pharmacology of new drugs."},"_companyIR":{"url":"https://www.pfizer.com/investors","revenueRefs":[],"pipelineRefs":[]},"commercial":{"yoyGrowth":"+7%","annualCostUS":"$80,000/yr","genericStatus":"Generic — off-patent","currentRevenue":"","patientPopulation":"~","peakSalesEstimate":""},"references":[{"id":1,"url":"https://clinicaltrials.gov/search?intr=pf-08049820-mr2","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=pf-08049820-mr2","fields":["publications"],"source":"PubMed/NCBI"},{"id":3,"url":"https://www.ebi.ac.uk/chembl/","fields":["molecular"],"source":"ChEMBL (EMBL-EBI)"},{"id":4,"url":"https://www.ema.europa.eu/","fields":["regulatoryStatus"],"source":"European Medicines Agency (EMA)"},{"id":5,"url":"https://list.essentialmeds.org/","fields":["regulatoryStatus"],"source":"WHO Essential Medicines List"}],"_tgaChecked":true,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-19T23:34:44.800539+00:00","fieldsConflicting":1,"overallConfidence":0.8},"_whoChecked":true,"biosimilars":[],"competitors":[{"name":"Rabeprazole","company":"Unknown","advantage":"Competes with PF-08049820 in a Phase 1 study to investigate the effect on pharmacokinetics"},{"name":"Birth control pills","company":"Unknown","advantage":"Competes with PF-08049820 in a Phase 1 study to investigate the effect on pharmacokinetics"}],"genericName":"pf-08049820-mr2","indications":{"approved":[{"name":"Multiple Myeloma","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 2 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 3 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 4 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 5 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 6 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 7 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 8 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 9 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 10 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 11 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 12 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 13 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 14 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 15 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 16 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 17 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 18 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 19 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 20 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 21 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 22 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 23 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 24 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 25 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 26 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 27 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 28 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 29 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 30 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 31 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 32 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 33 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 34 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 35 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 36 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 37 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 38 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 39 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 40 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 41 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 42 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 43 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 44 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 45 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 46 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 47 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 48 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 49 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 50 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 51 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 52 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 53 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 54 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 55 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 56 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 57 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 58 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 59 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 60 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 61 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 62 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 63 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 64 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 65 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 66 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 67 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 68 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 69 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 70 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 71 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 72 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 73 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 74 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 75 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 76 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 77 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 78 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 79 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 80 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 81 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 82 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 83 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 84 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 85 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 86 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 87 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 88 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 89 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 90 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 91 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 92 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 93 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 94 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 95 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 96 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 97 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 98 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 99 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 100 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 101 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 102 prior therapies","regulator":"FDA"},{"name":"Relapsed or Refractory Multiple Myeloma after at least 103 prior therapies","regulator":"FDA"}],"offLabel":[],"pipeline":[]},"_mhraChecked":true,"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07172321","phase":"PHASE1","title":"A Study to Learn How Different Forms of the Study Medicine Called PF 08049820 Are Taken up Into the Bloodstream in Healthy Adults","status":"COMPLETED","sponsor":"Pfizer","startDate":"2025-09-05","conditions":"Atopic Dermatitis","enrollment":12}],"_emaApprovals":[{"date":"","name":"PF-08049820 MR2","status":"Authorised","regulator":"EMA"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"molecularData":{"oral":false,"chemblId":"CHEMBL4518706","moleculeType":"Unknown","molecularWeight":"508.49"},"_patentsChecked":true,"_warningLetters":[{"date":"03/28/2023","subject":"11/07/2022\tTodos Medical Ltd aka Todos Medical USA Inc\tCenter for Food Safety and Applied Nutrition"},{"date":"03/27/2026","subject":"Feedback form"}],"crossReferences":{"chemblId":"CHEMBL4518706"},"formularyStatus":[],"_offLabelChecked":true,"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Oncology"],"biosimilarFilings":[],"recentPublications":[],"_drugWebsiteChecked":true,"_healthCanadaChecked":true,"companionDiagnostics":[],"_genericFilersChecked":true,"genericManufacturerList":[],"phase":"marketed","status":"active","companyName":"Pfizer","companyId":"pfizer","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":9,"regulatoryByCountry":[{"country_code":"EU","regulator":"EMA","status":"pending","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"pricingByCountry":[{"country_code":"US","currency":"USD","price_amount":"80000.00","price_per":"year","price_type":"annual_list","annual_cost_usd":null,"reimbursement_status":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-19T23:34:44.800539+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}